PharmedOut
pharmed-out.bsky.social
PharmedOut
@pharmed-out.bsky.social
PharmedOut is a project at Georgetown that advances evidence-based prescribing and provides education about pharmaceutical and medical device marketing practices.
Fugh-Berman quoted in BMJ article: Menopausal hormone therapy "should not be used for disease prevention, and it should not be used to treat symptoms that are not associated with menopause. " Jennifer Block exposes Let’s Talk Menopause...
www.bmj.com/content/391/...
How a menopause campaign with industry ties became official US policy
The removal of a warning label on menopausal hormone therapies has been hailed as a win for a US advocacy campaign. But the origins of that campaign suggest industry is laying the groundwork for a wid...
www.bmj.com
December 2, 2025 at 9:35 PM
New publication shines a light on who testifies at #FDA Advisory Committee meetings. "The FDA should consider strategies to solicit input from a broader array of stakeholders and mitigate COI among public participants."
jamanetwork.com/journals/jam...
Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with...
jamanetwork.com
December 2, 2025 at 9:33 PM
"Drug samples aren’t charity...they are intended to influence prescribing. The best way to curb pharmaceutical marketing and support evidence-based, cost-effective treatments is to ban drug samples." Butler et. al in
www.healthaffairs.org/content/fore...
Free Samples: Pharma’s Best Marketing Strategy | Health Affairs Forefront
The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics.
www.healthaffairs.org
November 24, 2025 at 4:50 PM
“The direction of travel is clear: Pharma is moving closer to the patient.” Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers? | PharmExec
www.pharmexec.com/view/pharma-...
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers? | PharmExec
As leading drugmakers launch direct-to-patient platforms with steep discounts and digital care bundles, a new channel dynamic is emerging that gives manufacturers greater control of patient engagement...
www.pharmexec.com
November 24, 2025 at 4:49 PM
Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade. - WSJ
www.wsj.com/health/welln...
Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.
Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been studied closely. ‘I was living in a body hijacked by the medication.’
www.wsj.com
November 24, 2025 at 4:48 PM
More evidence that ibuprofen and acetaminophen are better than opioids for dental pain... jamanetwork.com/journals/jam...
Analgesic Differences in Males and Females After Third Molar Surgery
This prespecified subgroup analysis of a randomized clinical trial investigates noninferiority for pain relief, treatment effects, and patient satisfaction for nonopioids vs opioids in male and female...
jamanetwork.com
November 24, 2025 at 4:48 PM
Excellent article from
@motherjones.com Menopause "doesn’t kill women or cause divorce." www.motherjones.com/politics/202...
The many problems with the FDA’s big menopause announcement
No, it doesn't kill women or cause divorce.
www.motherjones.com
November 24, 2025 at 4:46 PM
Fugh-Berman on Makary's "expert" panels: “they are rife with people with conflicts of interests, include unqualified people, lack any public comment section, and are full of people spouting their often uninformed opinions rather than assessing data” insidehealthpolicy.com/share/151820
| InsideHealthPolicy.com
insidehealthpolicy.com
November 18, 2025 at 7:59 PM
Fugh-Berman on the FDA deleting risks from menopausal hormone therapy label: “an embarrassment...They presented opinion as fact, and they misrepresented epidemiological evidence.” Jennifer Block's article in The Free Press:
www.thefp.com/p/estrogen-i...
Estrogen Is Back
Estrogen for menopause was demonized for decades. Now some vocal, very online doctors are saying it’s a miracle drug. The FDA appears to agree. Jennifer Block reports on the latest.
www.thefp.com
November 18, 2025 at 7:58 PM
Carl Elliott and Lauren Wilson on how Hennepin Healthcare ketamine studies violated federal research guidelines. Without consent, people were injected with a dangerous drug for a research study on the made-up condition "excited delirium".
onlinelibrary.wiley.com/doi/10.1002/...
The Hennepin Healthcare Forced Ketamine Studies, Excited Delirium, and Police Violence
In the summer of 2018, the Minneapolis Star Tribune reported clinical trials at Hennepin County Medical Center in which emergency medical personnel were injecting agitated individuals with ketamine, ...
onlinelibrary.wiley.com
November 18, 2025 at 7:58 PM
The Lever released a searchable database of 429 drugs approved by the FDA between 2013 and 2022 and a color-coded assessment of the scientific evidence submitted by drugmakers.
www.levernews.com/do-your-drug...
Do Your Drugs Work? A Searchable Database
Use this search tool to evaluate the scientific evidence — or lack thereof — behind hundreds of FDA-approved medicines.
www.levernews.com
November 18, 2025 at 7:57 PM
Great extensive article by Brownlee and Lenzer in the Lever on the long downward slide of the FDA. Fugh-Berman quoted: “Drug companies want advisory committees to listen to the emotions and not look at the science.”
www.levernews.com/science-for-...
Science For Sale: How Drugmakers Captured The FDA
The pharmaceutical industry spent decades manipulating the country’s top drug regulator into rubber-stamping its products. The Trump administration is making matters worse.
www.levernews.com
November 17, 2025 at 8:45 PM
Unreliable external fetal monitoring drives unconscionably high U.S. C-section rate ... Link: www.nytimes.com/2025/11/06/h...
The ‘Worst Test in Medicine’ is Driving America’s High C-Section Rate
www.nytimes.com
November 17, 2025 at 8:44 PM
Notorious GSK paroxetine adolescent depression trial is slapped with expression of concern amid legal action
www.bmj.com/content/391/...
Notorious GSK paroxetine adolescent depression trial is slapped with expression of concern amid legal action
A long criticised study on antidepressant use in adolescents has been flagged with an “expression of concern” by a leading academic journal after the launch of legal action.12 George Murgatroyd III, ...
www.bmj.com
November 17, 2025 at 8:25 PM
Paul Offit: Raw milk advocate RFK Jr. endangers children: eliminates FDA Milk Quality Testing branch and limits CDC monitoring foodborne outbreaks. Expect an epidemic of Salmonella, Listeria, Campylobacter, and toxin-producing E. coli infections. pauloffit.substack.com/p/see-no-evi...
See No Evil
Why did RFK Jr. limit the reporting of certain foodborne illnesses?
pauloffit.substack.com
November 17, 2025 at 8:24 PM
Novo spent about $7.5 million on more than 15 000 paid keywords over 2 years, generating 2.4 million paid visits to Ozempic’s website. (23% of keywords did not mention the drug).
link: jamanetwork.com/journals/jam...
GLP-1RAs and Pay-Per-Click Direct-to-Consumer Advertising
This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA).
jamanetwork.com
November 17, 2025 at 8:24 PM
For-profit IRBs approve unethical trials, and put patients' lives at risk
www.nytimes.com/2025/10/04/h...
How Private Equity Oversees the Ethics of Drug Research
www.nytimes.com
October 24, 2025 at 3:15 PM
The Women's Health Initiative (WHI) investigators eviscerate attacks made on the WHI's by Marty Makary's panel on menopausal hormone therapy at the FDA
www.regulations.gov/comment/FDA-...
Regulations.gov
www.regulations.gov
October 24, 2025 at 3:14 PM
Reposted by PharmedOut
"Long story short: after-the-fact warning letters won't do much to move the needle."

Read the #OpEd from Adriane Fugh-Berman, MD, and Judy Butler, MS on drug advertising at: https://www.medpagetoday.com/opinion/second-opinions/117698?trw=no
Opinion | Will Cracking Down on Drug Ads Help Patients?
There are better ways to curb rising prescription rates and drug use
www.medpagetoday.com
September 30, 2025 at 11:54 PM
"They know your age, your sex, your medications, your hospitalizations, your illnesses, and the zip code where you live..." Dr. Adriane Fugh-Berman told Straight Arrow News on pharmaceutical companies and consumer's health care data. #pharma t.co/OoOD9isjfl
https://www.youtube.com/watch?v=9TKFdGl86mU
t.co
October 15, 2025 at 3:25 PM
Opinion | Fugh-Berman and Butler in MedPage Today: ”curbing DTC drug advertising is unlikely to achieve the goal of curbing excessive prescriptions or rising drug spending.. regulatory actions should focus on banning disease awareness campaigns.”
www.medpagetoday.com/opinion/seco...
Opinion | Will Cracking Down on Drug Ads Help Patients?
There are better ways to curb rising prescription rates and drug use
www.medpagetoday.com
October 15, 2025 at 3:23 PM
Judy Butler and A Fugh-Berman oppose proposed menopause laws: "By reflecting industry positions, media coverage not only conveys the message that there is widespread support for menopause laws, it also legitimizes the need for these laws."
www.nj.com/opinion/2025...
Hey, Jersey lawmakers! Get your story straight about menopause | Opinion
Lawmakers must rely only on non-conflicted sources of information about healthcare and consider the implications of laws implemented without respect to evidence.
www.nj.com
October 15, 2025 at 3:23 PM
Lydia Greene's moving account of how she became a whistleblower: Confessions of an Advertising Writer: What I Learned From Your Stories—And Mine - Mad In America
www.madinamerica.com/2025/09/conf...
Confessions of an Advertising Writer: What I Learned From Your Stories—And Mine
Apologies won’t undo the harm. What I’ve learned might. The current system will not change unless we organize.
www.madinamerica.com
September 18, 2025 at 2:22 PM
Most physicians still believe that pharmaceutical marketing provides useful information, free drug samples are good for patients, and gifts under $50 are OK to receive
jamanetwork.com/journals/jam...
jamanetwork.com
September 18, 2025 at 2:21 PM